Scout Investments, Inc. Incyte Corp Transaction History

Scout Investments, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 10, 2019	SELL	$73.52 - $88.7 $3.8 Million - $4.59 Million	-51,718 Closed	0 $0
Q1 2019 Apr 12, 2019	SELL	$63.56 - $88.17 $12.5 Million - $17.3 Million	-196,335 Reduced 79.15%	51,718 $4.45 Million
Q4 2018 Jan 11, 2019	BUY	$58.5 - $69.94 $872,469 - $1.04 Million	14,914 Added 6.4%	248,053 $15.8 Million
Q3 2018 Oct 15, 2018	BUY	$61.75 - $74.23 $780,026 - $937,673	12,632 Added 5.73%	233,139 $16.1 Million
Q2 2018 Jul 16, 2018	BUY	$60.85 - $83.98 $13.4 Million - $18.5 Million	220,507 New	220,507 $14.8 Million
Q1 2018 May 09, 2018	SELL	$83.06 - $100.98 $3.9 Million - $4.74 Million	-46,916 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$93.56 - $116.6 $8.61 Million - $10.7 Million	-92,011 Closed	0 $0
Q3 2017 Nov 03, 2017	BUY	$109.15 - $138.27 $1.18 Million - $1.49 Million	10,792 Added 13.29%	92,011 $10.7 Million
Q2 2017 Aug 08, 2017	BUY	N/A	81,219	81,219 $10.2 Million

643

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Scout Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Scout Investments, Inc. with notifications on news.